Appili Therapeutics Inc. (APLIF)
OTCMKTS · Delayed Price · Currency is USD
0.0220
0.00 (0.00%)
Apr 23, 2025, 4:00 PM EDT

Appili Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Apr '25 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2017 - 2019
Market Capitalization
23475522
Upgrade
Market Cap Growth
-8.22%-12.57%-47.66%-87.63%148.85%-
Upgrade
Enterprise Value
109724021
Upgrade
Last Close Price
0.020.020.030.100.87-
Upgrade
PS Ratio
25.185.1314.526.15-158.47
Upgrade
PB Ratio
-0.23-0.39-0.66-2.615.463.57
Upgrade
P/TBV Ratio
----5.463.57
Upgrade
EV/Sales Ratio
113.2714.0826.531.57-151.31
Upgrade
Debt / Equity Ratio
-0.83-0.75-1.04-1.520.080.11
Upgrade
Asset Turnover
0.060.360.060.11-0.02
Upgrade
Quick Ratio
0.130.110.971.213.867.88
Upgrade
Current Ratio
0.140.131.051.243.968.06
Upgrade
Return on Equity (ROE)
----529.79%-132.65%-81.66%
Upgrade
Return on Assets (ROA)
-306.73%-217.68%-86.67%-115.98%-66.38%-42.56%
Upgrade
Return on Capital (ROIC)
---500.52%-199.10%-82.82%-49.81%
Upgrade
Earnings Yield
-125.95%-89.08%-190.55%-293.71%-20.56%-17.17%
Upgrade
FCF Yield
-19.88%-58.76%-208.24%-223.12%-16.45%-13.51%
Upgrade
Buyback Yield / Dilution
-0.03%-6.63%-70.43%-12.76%-72.40%-13.47%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.